Company and Case Information

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors


Register


_______________
Copyright (c) 2001
Stanford Law School


Merck & Co., Inc.
Summary: According to a press release dated December 20, 2005, the 3rd U.S. Circuit Court of Appeals has now ruled that the investors' suit was properly dismissed because Merck had disclosed the nature of its subsidiary's improper accounting practices in an April 2001 filing with the Securities & Exchange Commission, and that the Journal reporter "simply did the math." Although the court was critical of Merck's failure to disclose the actual figures in its SEC filing, it nonetheless found that the essential facts had been disclosed to investors and analysts.

The original complaint allege that Merck overstated revenues from its subsidiary Merck-Medco Managed Care, L.L.C. by billions of dollars by including consumer co-payments for prescription drugs in its revenues. During the Class Period, Merk-Medco's revenues made up over 50% of Merck's total revenues. The lawsuit claims that Merck violated Generally Accepted Accounting Practices (GAAP) because neither company bills for the co-payments, gets billed for them, or otherwise comes into contact with co-payment money. Patients make co-payments directly to pharmacies when they purchase medicine.

On June 21, 2002, The Wall Street Journal issued a report regarding Merck's accounting practices and estimated that Merck and Merck-Medco may have pumped up their 2001 revenues by as much as $4.6 billion. Similar overstatements may have occurred for 1999 and 2000, the complaint says. That same day, according to the complaint, a Merck spokesman admitted that the company had been recording prescription drug co-payments as revenue since it acquired Merck-Medco in 1993.

In the wake of these revelations, Merck's stock immediately dropped 4.25% from its closing price of $52.20 on June 20, 2002 to a closing price of $49.98 on June 21, 2002, its lowest closing price since late 1997.

Through August 30, 2002, various plaintiff firms' motions for consolidation of all related actions and for the appointment of Lead Plaintiff and Lead Counsel were filed with the Court. The cases were consolidated on September 19, 2002. Lead Plaintiff, and their selection of Lead Counsel, was appointed on November 27, 2002. Lead Plaintiffs filed an Amended Complaint on March 17, 2003, which Defendants moved to dismiss on May 14, 2003. To date, the docket reflects no further significant activity.

INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Major Drugs


COMPANY/ISSUER NAME: Merck & Co., Inc.
COMPANY/ISSUER TICKER: MRK
COMPANY WEBSITE: http://www.merck.com

FIRST IDENTIFIED COMPLAINT IN THE DATABASE
Deutschl, et al. v. Merck & Co., Inc., et al.
 COURT: D. New Jersey  DOCKET NUMBER: 02-CV-3185
 JUDGE NAME: Hon. Mary L. Cooper
 DATE FILED: 07/01/2002  SOURCE: Business Wires
 CLASS PERIOD START: 07/01/1999  CLASS PERIOD END: 06/21/2002
 TYPE OF COMPLAINT: Unamended/Unconsolidated
 PLAINTIFF FIRMS IN THIS OR SIMILAR CASE:
  • Alfred G. Yates, Jr.
      429 Forbes Avenue, Pittsburgh , PA, 15219
       (voice) 412.391.5164, (fax) ,
  • Berman DeValerio Pease Tabacco Burt & Pucillo (MA)
      One Liberty Square, Boston, MA, 2109
       (voice) 617.542.8300, (fax) 617.230.0903, info@bermanesq.com
  • Glancy and Binkow
      1801 Avenue of the Stars, suite 311, Los Angeles, CA, 90067
       (voice) 310-201-9150, (fax) , info@glancylaw.com
  • Holzer & Holzer, LLC
      1117 Perimeter Center West, Suite E-107, Atlanta, GA, 30338
       (voice) (770) 392-0090, (fax) (770) 392-0029, mfistel@holzerlaw.com
  • Kaplan Fox & Kilsheimer, LLP (San Francisco, CA)
      100 Pine Street, 26th Floor, San Francisco, CA, 94111
       (voice) 415.772.4700, (fax) 415.677.1233, info@kaplanfox.com
  • Kirby McInerney & Squire LLP
      830 Third Avenue 10th Floor, New York Ave, NY, 10022
       (voice) 212.317.2300, (fax) ,
  • Law Offices of Marc S. Henzel
      335 Central Avenue, Lawrence, NY, 11559
       (voice) 516.374.0707, (fax) 516.295.3473, securitiesfraud@comcast.net
  • LeBlanc & Waddell, LLC
      201 St. Charles Avenue, Suite 3204, New Orleans, LA, 70170
       (voice) 504.523.9900, (fax) 504.522.9300,
  • Lite, DePalma, Greenberg & Rivas, LLC
      Two Gateway Center, 12th Floor, Newark, NJ, 07102-5003y C
       (voice) 973.623.3000, (fax) ,
  • Milberg Weiss Bershad Hynes & Lerach LLP (New York, NY)
      One Pennsylvania Plaza, New York, NY, 10119-1065
       (voice) 212.594.5300, (fax) ,
  • Rabin & Peckel LLP
      275 Madison Avenue, 34th Floor, New York, NY, 10016
       (voice) 212.682.1818, (fax) 212.682.1892, email@rabinlaw.com
  • Shapiro Haber & Urmy LLP
      75 State Street, Boston, MA, 02109
       (voice) 617.439.3939, (fax) 617.439.0134, info@shulaw.com
  • Spector Roseman & Kodroff (San Diego)
      1818 Market Street, Suite 2500, Philadelphia, PA, 19103
       (voice) 215.496.0300, (fax) 215.496.6611,
  • Wechsler Harwood LLP
      488 Madison Avenue 8th Floor, New York, NY, 10022
       (voice) 212.935.7400, (fax) , info@whhf.com
  • Weiss & Yourman (New York, NY)
      The French Building, 551 Fifth Ave., Suite 1600, New York, NY, 10126
       (voice) 212.682.3025, (fax) 212.682.3010, info@wyca.com
  • Wolf Popper, LLP
      845 Third Avenue, New York, NY, 10022-6689Ave
       (voice) 877.370.7703, (fax) 212.486.2093, IRRep@wolfpopper.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  16

  •  DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
    Class Action Complaint - Jury Trial Demanded
    Type: Complaint Date on the document: 07/01/2002
    US District Court Civil Docket
    Type: Docket Date on the document: 09/15/2003

    REFERENCE COMPLAINT
    In Re: Merck & Co., Inc. Securities Litigation
     COURT: D. New Jersey  DOCKET NUMBER: 02-CV-3185
     JUDGE NAME: Hon. Stanley R. Chesler
     DATE FILED: 03/21/2003  SOURCE: Business Wires
     CLASS PERIOD START: 01/26/2000  CLASS PERIOD END: 07/09/2002
     TYPE OF COMPLAINT: Consolidated and/or Amended
     PLAINTIFF FIRMS NAMED IN COMPLAINT:
  • Bernstein Litowitz Berger & Grossmann LLP (New York, NY)
      1285 Avenue of the Americas, 33rd Floor, New York, NY, 10019
       (voice) 212.554.1400, (fax) 212.554.1444, blbg@blbglaw.com
  • Bernstein Litowitz Berger & Grossmann LLP (Westfield, NJ)
      220 St. Paul Street, Westfield, NJ, 07090
       (voice) 908.928.1700, (fax) 908.301.9008, blbg@blbglaw.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  2

  •  DOCUMENTS FOR THE REFERENCE COMPLAINT
    (Corrected) Consolidated Amended Class Action Complaint For Violations Of The Federal Securities Laws
    Type: Complaint Date on the document: 03/21/2003
    Order
    Type: Order Date on the document: 07/07/2004
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 12/16/2005

     OTHER DOCUMENTS
    Class Action Complaint For Violations Of Federal Securities Law
    Case Name and/or Number: Knisley, et al. v. Merck & Co., Inc., et al.
    Type: Complaint Date on the document: 07/02/2002

    WARNING AND DISCLAIMER OF LIABILITY:
    The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
    Go to Search  page | Go to Case Index  page | Back to Top